Table 3.
Characteristics of kidney recipients and functional outcomes
| Recipient | Age, yr | Sex | Kidney disease | Cold ischemia time, h | LOS, d | Delayed graft function | Postoperative dialysis, d | sCr:CrCl, μmol/L:mL/min | Follow-up, mo | |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 months | 12 months | |||||||||
| 1 | 59 | F | Chronic glomerulonephritis | 3.5 | 13 | No | 0 | 112:52 | 107:54 | 20 |
| 2 | 61 | F | Polycystic | 4.5 | 14 | No | 0 | 102:60 | 109:56 | 20 |
| 3 | 55 | M | Diabetes | 4 | 20 | Yes | 10 | 122:82 | 122:83 | 20 |
| 4 | 49 | M | Hypertension | 8.5 | 15 | Yes | 9 | 157:37 | 145:41 | 20 |
| 5 | 59 | M | Wegener disease | 9 | 16 | Yes | 16 | 194:49 | 220:43 | 15 |
| 6 | 62 | M | Unknown | 4.25 | 15 | Yes | 13 | 164:54 | 149:59 | 15 |
| 7 | 36 | M | Polycystic | 4.25 | 16 | Yes | 10 | 189:61 | 146:83 | 14 |
| 8 | 45 | M | IgA nephropathy | 9.5 | 29 | Yes | 25 | 182:59 | 186:57 | 14 |
| 9 | 55 | M | Polycystic | 8.25 | 16 | Yes | 19 | 160:61 | 126:96 | 14 |
| 10 | 44 | M | Focal and segmental | 4 | 16 | Yes | 13 | 155:70 | 145:90 | 14 |
| glomerulosclerosis | ||||||||||
| 11 | 68 | M | Diabetes | 3 | 15 | Yes | 11 | 192:38 | 166:47 | 13 |
| 12 | 57 | M | Calcineurin inhibitor toxicity | 7 | 18 | Yes | 12 | 121:64 | 120:61 | 13 |
| 13 | 49 | M | Focal and segmental glomerulosclerosis | 13 | 12 | Yes | 2 | 160:54* | — | 3 |
| 14 | 77 | M | Hypertension | 25.5 | 11 | Yes | 5 | 109:61* | — | 3 |
CrCl = estimated creatinine clearance; F = female; LOS = length of stay; M = male; sCr = serum creatinine.
*
Value at 3-month follow-up.